REFERENCES
- Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nature Genet 1998;19:241–247
- Marquardt A, Stohr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Hum Mol Genet 1998;7:1517–1525
- Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 2004;45:3683–3689
- Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 2008;82:19–31
- Kaufman SJ, Goldberg MF, Orth DH, et al. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 1982;100:272–278
- Blair NP, Goldberg MF, Fishman GA, et al. Autosomal dominant vitreoretinochoroidopathy (ADVIRC). Br J Ophthalmol 1984;68:2–9
- Traboulsi EI, Payne JW. Autosomal dominant vitreoretinochoroidopathy. Report of the third family. Arch Ophthalmol 1993;111:194–196
- Roider J, Fritsch E, Hoerauf H, et al. Autosomal dominant vitreoretinochoroidopathy. Retina 1997;17:294–299
- Kellner U, Jandeck C, Kraus H, et al. Autosomal dominant vitreoretinochoroidopathy with normal electrooculogram in a German family. Graefes Arch Clin Exp Ophthalmol 1998;236:109–114
- Lafaut BA, Loeys B, Leroy BP, et al. Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol 2001;239:575–582
- Oh KT, Vallar C. Central cone dysfunction in autosomal dominant vitreoretinochoroidopathy (ADVIRC). Am J Ophthalmol 2006;141:940–943
- Vincent A, McAlister C, Vandenhoven C, et al. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies. Eye 2011;25:113–118
- Chen CJ, Goldberg MF. Progressive cone dysfunction and geographic atrophy of the macula in late stage autosomal dominant vitreoretinochoroidopathy (ADVIRC). Ophthalmic Genet 2016;37:81–85
- Burgess R, Maclaren R, Davidson A, et al. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet 2009;46:620–625
- Marmor MF, Fulton AB, Holder GE, et al. Standard for clinical electroretinography (2008 update). Doc Ophthalmol 2009;118:69–77
- Hood DC, Bach M, Brigell M, et al. ISCEV Standard for clinical multifocal electroretinography (2011 edition). Doc Ophthalmol 2012;124:1–13
- Kellner U, Kellner S, Weber BH, et al. Lipofuscin- and melanin-related fundus autofluorescence visualize different retinal pigment epithelial alterations in patients with retinitis pigmentosa. Eye 2009;23:1349–1359
- Kellner S, Kellner U, Weinitz S. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 2009;93:1444–1447
- Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975;94:441–448
- Apushkin MA, Fishman GA. Use of dorzolamide for patients with X-linked retinoschisis. Retina 2006;26:741–745
- Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850–858
- Fishman GA, Apushkin MA. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 2007;91:743–745
- Robson AG, Michaelides M, Saihan Z, et al. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update. Doc Ophthalmol 2008;116:79–89
- Goldberg MF, Lee FL, Tso MO, et al. Histopathologic study of autosomal dominant vitreoretinochoroidopathy. Peripheral annular pigmentary dystrophy of the retina. Ophthalmology 1989;96:1736–1746
- Han DP, Burke JM, Blair JR, et al. Histopathologic study of autosomal dominant vitreoretinochoroidopathy in a 26-year-old woman. Arch Ophthalmol 1995;113:1561–1566